[Semisynthetic Diosmin (Phlebodia 600) for therapy of lower limb chronic venous insufficiency].
The study was held to assess clinical effectiveness of coaggregated semisynthetic Diosmin (Phlebodia 600) for patients with II-III CEAP classes of chronic venous insufficiency (CVI), caused by lower limb variceal diseases. In 30 cases Phlebodia 600 demonstrated positive effect on CVI symptoms, edematous and convulsive syndromes. The authors conclude that Phlebodia 600 is highly effective and safe for patients with CVI.
Kirienko
A I
AI
Bogachev
V Iu
VIu
Zolotukhin
I A
IA
Golovanova
O V
OV
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D002908:Chronic Disease; D004145:Diosmin / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007866:Leg / Q000098:blood supply*; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome; D014689:Venous Insufficiency / Q000188:drug therapy*
D004145:Diosmin